Fetal Bovine Serum Market Report 2026

Fetal Bovine Serum Market Overview

• Fetal Bovine Serum market size has reached to $1.06 billion in 2025 • Expected to grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Rising Global Demand For Dairy And Meat Products Fuels Growth In The Bovine Artificial Insemination Market • Market Trend: Innovations In Animal-Component-Free Alternatives For Sustainable Cell Culture • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Fetal Bovine Serum Market?

Fetal bovine serum refers to a typical element of animal cell culture media that is utilized to support the growth of eukaryotic cells cultured in vitro. It is obtained by harvesting bovine fetuses from pregnant cows who were about to be slaughtered. FBS is frequently obtained with a cardiac puncture without the use of any type of anesthesia. The main types of fetal bovine serum are charcoal stripped, chromatographic, dialyzed fetal bovine serum, exosome depleted, stem cell, others. Charcoal-stripped fetal bovine serum has activated carbon that helps lower levels of lipophilic compounds such as hormones, growth factors, and steroids and is used to conduct receptor or estrogen related studies. Dialyzed fetal bovine serum has reduced concentration of low molecular weight components such as nucleotides, amino acids, hormones, salts and various small proteins in serum and is used in cell culture systems requiring a more defined environment of small molecules. Exosome depleted fetal bovine serum isolates exosomes from cultured cells without the complication of bovine exosomes that are present in conventional FBS and is used for research on exosomes. The fetal bovine serum is used in drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, others. Fetal bovine serum is used in various sectors including research and academic institutes, biotechnology and pharmaceutical industry, others.

What Is The Fetal Bovine Serum Market Growth Forecast?

The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to shift towards serum-free and xeno-free alternatives, rising demand for precision medicine, increasing investments in biotech research, expansion of human and animal vaccine production, adoption of automated cell culture systems. Major trends in the forecast period include enhanced cell culture media formulations, serum-free and alternative media development, quality standardization and regulatory compliance, increasing adoption in vaccine production, expansion in academic and research applications.

Global Fetal Bovine Serum Market Segmentation

1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products 2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human And Animal Vaccine Production, Diagnostics, Other Applications 3) By End-User: Research And Academic Institutes, Biotechnology And Pharmaceutical Industry, Other End-Users Subsegments: 1) By Charcoal Stripped: Standard Charcoal Stripped FBS, Heat-Inactivated Charcoal Stripped FBS 2) By Chromatographic: Ion Exchange Chromatography Purified FBS, Affinity Chromatography Purified FBS 3) By Dialyzed Fetal Bovine Serum: Standard Dialyzed FBS, Heat-Inactivated Dialyzed FBS 4) By Exosome Depleted: Standard Exosome Depleted FBS, Heat-Inactivated Exosome Depleted FBS 5) By Stem Cell: Stem Cell Grade FBS, Knockout Serum Replacement 6) By Other Products: Serum from Specific Animal Breeds, Custom-Processed FBS

What Is The Driver Of The Fetal Bovine Serum Market?

The growing demand for dairy and meat products is expected to propel the growth of the fetal bovine artificial insemination market. Dairy and meat products refer to consumable goods derived from milk processing and livestock slaughter, including items such as cheese, yogurt, beef, and pork. The increased awareness about the health benefits of consuming protein, calcium, and other nutrients in dairy and meat products has driven demand for dairy and meat products. Fetal Bovine supports the growing demand for dairy and meat products by enhancing herd genetics, improving reproductive efficiency, and increasing the productivity and quality of livestock. For instance, in August 2023, according to the European Commission (EC), the Belgium-based executive branch of the European Union (EU), raw milk production in the EU saw a 0.8% increase during the initial 6 months of 2023. Therefore, the growing demand for dairy and meat products is driving the growth of the fetal bovine market.

Key Players In The Global Fetal Bovine Serum Market

Major companies operating in the fetal bovine serum market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Cytiva, VWR International, Sartorius AG, Bio-Techne Corporation, Atlas Biologicals Inc., R&D Systems Inc., Atlanta Biologicals Inc., Cyagen Biosciences, GenClone Inc., Gemini Bio-Products, Access Biologicals LLC, Nucleus Biologics, ZenBio Inc., Biowest, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., J R Scientific Inc., Rocky Mountain Biologicals Inc., Tissue Culture Biologicals, Moregate Biotech, Cell Applications Inc., Altogen Biosystems, Axil Scientific Pte Ltd., Animal Technologies Inc., PAN- Biotech, PAA Laboratories GmbH, Peak Serum Inc.

Global Fetal Bovine Serum Market Trends and Insights

Major companies operating in the fetal bovine serum market are focusing on developing innovative solutions such as animal-component free alternatives to enhance sustainability, reduce ethical concerns, and support the growing cultivated meat and cell culture industries. An animal-component-free alternative is a serum substitute that promotes cell growth in culture without containing any animal-derived ingredients. For instance, in December 2024, Multus Biotechnology Limited, a UK-based biotech company, launched Proliferum B for cultivated meat production. This product supports robust cell growth, reduces reliance on animal sources, and accelerates the commercialization of sustainable cultured meat products. By offering a scalable and ethically sourced solution, Multus aims to address both cost and supply constraints in the cultivated meat industry while promoting more sustainable protein production.

What Are Latest Mergers And Acquisitions In The Fetal Bovine Serum Market?

In August 2023, URUS Group LP, a US-based company serving dairy and beef cattle producers with genetic solutions, data management, and consulting, acquired Leachman Cattle for an undisclosed amount. This acquisition of Leachman Cattle by URUS Group LP strengthens URUS's leadership in global cattle genetics by incorporating Leachman's advanced technologies and extensive database to accelerate genetic progress, improve beef production sustainability, and expand URUS's global reach. Leachman Cattle is a US-based provider of high-quality beef genetics through bulls, females, and semen for bovine artificial insemination.

Regional Insights

North America was the largest region in the fetal bovine serum market in 2025. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Fetal Bovine Serum Market?

The fetal bovine serum market consists of sales of Ultra-low IgG, ES Cell, MSC and Exosome-Depleted. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Fetal Bovine Serum Market Report 2026?

The fetal bovine serum market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the fetal bovine serum industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.